The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.89BCNY
879.04M · vs all stocks (USD)
Updated Sep 19, 2026
Revenue (TTM)
1.32BCNY
196.27M · vs all stocks (USD)
Updated Sep 19, 2026
Profit Margin
-14.03%
vs Scientific & Technical Instruments peers
Updated Sep 19, 2026
Beta
0.2590x
vs all stocks
Updated Sep 19, 2026
52-Week Change
-11.46%
vs all stocks
Updated Sep 19, 2026
Market Capitalization
5.89BCNY
879.04M · vs all stocks (USD)
Updated Sep 19, 2026
Enterprise Value
5.84BCNY
871.31M · vs all stocks (USD)
Updated Sep 19, 2026
Forward P/E
9.95x
vs Scientific & Technical Instruments peers
Updated Sep 19, 2026
Price to Sales (TTM)
4.42x
vs Scientific & Technical Instruments peers
Updated Sep 19, 2026
Price to Book (MRQ)
4.00x
vs Scientific & Technical Instruments peers
Updated Sep 19, 2026
Enterprise to Revenue
4.44x
vs Scientific & Technical Instruments peers
Updated Sep 19, 2026
Enterprise to EBITDA
-51.51x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 159.08×.Updated Sep 19, 2026
Gross Margin
41.68%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 36.61%.Updated Sep 19, 2026
Profit Margin
-14.03%
vs Scientific & Technical Instruments peers
Updated Sep 19, 2026
Operating Margin
-11.07%
vs Scientific & Technical Instruments peers
Updated Sep 19, 2026
Return on Assets (TTM)
-2.94%
vs Scientific & Technical Instruments peers
Updated Sep 19, 2026
Return on Equity (TTM)
-12.21%
vs Scientific & Technical Instruments peers
Updated Sep 19, 2026
Revenue (TTM)
1.32BCNY
196.27M · vs all stocks (USD)
Updated Sep 19, 2026
Revenue per Share (TTM)
1.77CNYUpdated Sep 19, 2026
Quarterly Revenue Growth
-9.90%
vs Scientific & Technical Instruments peers
Updated Sep 19, 2026
Gross Profit (TTM)
481.66MCNY
71.85M · vs all stocks (USD)
Updated Sep 19, 2026
EBITDA (TTM)
36.72MCNY
5.48M · vs all stocks (USD)
Updated Sep 19, 2026
Net Income (TTM)
-184.57MCNY
-27.53M · vs all stocks (USD)
Updated Sep 19, 2026
Quarterly Earnings Growth (YoY)
-12.52%
vs Scientific & Technical Instruments peers
Updated Sep 19, 2026
Operating Cash Flow (TTM)
70.09MCNY
10.45M · vs all stocks (USD)
Updated Sep 19, 2026
Levered Free Cash Flow (TTM)
-34.84MCNY
-5.20M · vs all stocks (USD)
Updated Sep 19, 2026
Payout Ratio
0.00%
vs Scientific & Technical Instruments peers
Updated Sep 19, 2026
Minority Interest (Equity)
38.69MCNYFY2025 · Dec 31, 2025
Revenue
1.37BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
834.04MCNYFY2025 · Dec 31, 2025
Gross Profit
535.36MCNYFY2025 · Dec 31, 2025
Operating Income
-13.62MCNY
-2.03M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-129.17MCNYFY2025 · Dec 31, 2025
Income Tax Expense
44.06MCNYFY2025 · Dec 31, 2025
Net Income
-173.23MCNYFY2025 · Dec 31, 2025
EBIT
-106.41MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
36.72MCNYFY2025 · Dec 31, 2025
Research & Development
75.09MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
95.44MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
10.21MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.70MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
22.76MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.2137CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.2137CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
740.38MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
740.38MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-173.23MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
15.01MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-8.72MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-28.79MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
668.77MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-173.23MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
24.65MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
132.83MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
7.03MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-20.07MCNYFY2025 · Dec 31, 2025
Net Acquisitions
945.05KCNYFY2025 · Dec 31, 2025
Sale of Investments
21.47MCNYFY2025 · Dec 31, 2025
Other Investing Activity
403.92KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
2.76MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
404.05MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-300.53MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-19.19MCNYFY2025 · Dec 31, 2025
Other Financing Charges
3.41MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
87.74MCNYFY2025 · Dec 31, 2025
Shares Outstanding
740.36MSharesUpdated Sep 19, 2026
Float Shares
423.97MSharesUpdated Sep 19, 2026
% Held by Insiders
45.61%
vs all stocks
Updated Sep 19, 2026
% Held by Institutions
0.30%
vs all stocks
Updated Sep 19, 2026
Total Cash (MRQ)
634.99MCNY
94.71M · vs all stocks (USD)
Updated Sep 19, 2026
Total Cash per Share (MRQ)
0.8580CNYUpdated Sep 19, 2026
Total Debt (MRQ)
625.28MCNY
93.27M · vs all stocks (USD)
Updated Sep 19, 2026
Total Debt to Equity (MRQ)
0.4203x
vs Scientific & Technical Instruments peers
Updated Sep 19, 2026
Current Ratio (MRQ)
1.88x
vs Scientific & Technical Instruments peers
Updated Sep 19, 2026
Book Value per Share (MRQ)
1.97CNYUpdated Sep 19, 2026
Total Assets
2.96BCNY
441.29M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.01BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.40BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
945.94MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
373.31MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.03BCNYFY2025 · Dec 31, 2025
Cash
668.72MCNYFY2025 · Dec 31, 2025
Cash Equivalents
36.68MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
705.40MCNYFY2025 · Dec 31, 2025
Accounts Receivable
820.42MCNYFY2025 · Dec 31, 2025
Inventory
344.48MCNYFY2025 · Dec 31, 2025
Accounts Payable
397.92MCNYFY2025 · Dec 31, 2025
Short-term Debt
286.32MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
34.24MCNYFY2025 · Dec 31, 2025
Long-term Debt
275.46MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
24.14MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
740.36MCNYFY2025 · Dec 31, 2025
Retained Earnings
-2.28BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.56BCNY
231.96M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
6.18CNYUpdated Sep 19, 2026
52-Week High
15.47CNYUpdated Sep 19, 2026
52-Week Change
-11.46%
vs all stocks
Updated Sep 19, 2026
Beta
0.2590x
vs all stocks
Updated Sep 19, 2026
50-Day MA
7.02CNYUpdated Sep 19, 2026
200-Day MA
9.29CNYUpdated Sep 19, 2026
Avg 10-Day Volume
42.24MSharesUpdated Sep 19, 2026
Avg 30-Day Volume
21.07MSharesUpdated Sep 19, 2026
Diluted EPS (TTM)
-0.2500CNYUpdated Sep 19, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable